Cosmo Pharmaceuticals (0RGI.L) Stock Price
CHF55.6 1.7%
to add to portfolio
AI Score
-
Alternative
8 -
Fundamental
9 -
Technical
5
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Cosmo Pharmaceuticals, AI stock picks, stock alerts and much more.
0RGI.L AI Stock Analysis
AI stock analysis for 0RGI.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Cosmo Pharmaceuticals (0RGI.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Cosmo Pharmaceuticals (0RGI.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Cosmo Pharmaceuticals (0RGI.L), currently trading at CHF55.6, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About 0RGI.L
-
Cosmo Pharmaceuticals N.
-
Symbol
0RGI.L
-
Market
LSE
-
Industry
Medical - Pharmaceuticals
-
Market Cap
892.2M
Similar Stocks
 |
Waters Corporation 0LTI.L |
$378.8 1.3% |
6 |
 |
Vertex Pharmaceuticals Incorporated 0QZU.L |
$514.7 0.2% |
6 |
 |
Neurocrine Biosciences 0K6R.L |
$109.8 2.3% |
6 |
 |
Emergent BioSolutions Inc. 0IGA.L |
$5.72 2.4% |
3 |
 |
Abeona Therapeutics Inc. 0H7R.L |
$5.18 0.5% |
4 |
News
0RGI.L Alternative Data
Web Traffic
Cosmo Pharmaceuticals receives an estimated 21489 monthly visitors to cosmopharma.com.
-
Web Traffic
21489
-
Change from Previous Month
69.8%
-
3 Month Change
93.7%
-
YoY Change
93.7%
News Mentions
Cosmo Pharmaceuticals was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Twitter Followers
Cosmo Pharmaceuticals has 223 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.5% over the last month.
-
Twitter Followers
223
-
Daily Change
0%
-
1 Month Change
0.5%
-
3 Month Change
1.4%
LinkedIn Followers
19,556 are following Cosmo Pharmaceuticals on LinkedIn, up by 4.2% over the last month.
-
LinkedIn Followers
19556
-
Daily Change
0.2%
-
1 Month Change
4.2%
-
3 Month Change
8.9%
Job Postings
Cosmo Pharmaceuticals currenly has an estimated 4 open job postings, up by 33.3% over the last month.
-
Job Postings
4
-
Daily Change
0%
-
1 Month Change
33.3%
-
3 Month Change
300%
Reddit Mentions
Cosmo Pharmaceuticals has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
LinkedIn Employees
According to LinkedIn, Cosmo Pharmaceuticals has 206 employees, up by 1.5% over the last month.
-
LinkedIn Employees
206
-
Daily Change
0%
-
1 Month Change
1.5%
-
3 Month Change
2%
Business Outlook
According to employee reviews, the business outlook among employees at Cosmo Pharmaceuticals is 100 out of 100 (very bullish).
-
Business Outlook
100
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
0RGI.L Financials
0RGI.L Key Metrics
-
Total Revenue
€68.1M
-
Net Income
€38M
-
Earnings per Share
€2.35
-
Free cash flow
€48.9M
-
EBITDA
€47.1M
-
EBITDA Ratio
0.69178
-
Total Assets
€638.3M
0RGI.L 2-year Revenue & Income
0RGI.L 2-year Free Cash Flow
0RGI.L Technicals
0RGI.L SMA
0RGI.L RSI
FAQ
What's the current price of Cosmo Pharmaceuticals (0RGI.L) Stock?
The price of an Cosmo Pharmaceuticals (0RGI.L) share is CHF55.6.
What's the market cap of Cosmo Pharmaceuticals?
The current market cap of Cosmo Pharmaceuticals is 892.2M.
Should I buy or sell 0RGI.L?
Multiple alternative data signals suggest that Cosmo Pharmaceuticals stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.
Is Cosmo Pharmaceuticals a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in Cosmo Pharmaceuticals stock. The bullish indicators suggest that Cosmo Pharmaceuticals' growth prospects and market position may lead to a positive performance in the foreseeable future.
Is now a good time to buy Cosmo Pharmaceuticals (0RGI.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying Cosmo Pharmaceuticals stock, given the bullish outlook.
What are some stocks similar to Cosmo Pharmaceuticals (0RGI.L) that investors often compare it to?
Cosmo Pharmaceuticals (0RGI.L) is often compared to similar stocks such as Waters Corporation, Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc. and Abeona Therapeutics Inc..
What is the forecast for Cosmo Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Cosmo Pharmaceuticals' stock price to be around CHF61.91 in 2026. Starting from the current price of CHF55.6, this represents a 11.4% change in price, indicating a bullish outlook for the stock.
How to buy Cosmo Pharmaceuticals (0RGI.L) Stock?
Cosmo Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Cosmo Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.